PT-141 (Bremelanotide) Therapy
PT-141 (Bremelanotide) Peptide Therapy in Jupiter, FL
PT-141, known generically as bremelanotide, takes a different approach to low libido than the medications most people have already tried. Where PDE5 inhibitors such as Viagra and Cialis act on blood flow, PT-141 works centrally — binding to melanocortin receptors in the brain to influence desire itself.
That distinction matters, because desire and mechanics are different problems. Patients who get an adequate physical response but have noticed that interest has simply faded are describing something a blood-flow medication was never designed to address.
Bremelanotide holds FDA approval under the brand name Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Its use in men is off-label. Dr. Ryan Brown, DO will tell you exactly where it stands before anything is prescribed.
RevitalIV offers PT-141 as part of a physician-supervised peptide therapy program at our clinic on West Indiantown Road, serving patients from Jupiter, Palm Beach Gardens, Tequesta, Juno Beach, North Palm Beach, and Hobe Sound.
PT-141 activates melanocortin receptors in the central nervous system to influence sexual desire directly, rather than acting on blood flow the way PDE5 inhibitors such as Viagra and Cialis do.
Very little. The injection uses a very fine subcutaneous needle, and most patients describe it as a brief pinch.
PT-141 is self-administered as a small subcutaneous injection, typically 45 minutes to 2 hours before sexual activity. It is used as needed rather than daily, and we cover injection technique during your visit at our Jupiter clinic.
The injection itself takes only seconds. Your initial consultation and lab review with Dr. Brown takes about 30 to 45 minutes.
The most common are temporary nausea, facial flushing, and mild headache, which usually resolve within a few hours. Bremelanotide can also cause a transient rise in blood pressure and a small drop in heart rate, so it is not appropriate for everyone — your cardiovascular history is reviewed before it is prescribed.
No downtime is required. You can return to normal activity immediately.
Bremelanotide is FDA approved for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. In clinical trials, women reported meaningful increases in sexual desire and reductions in the distress associated with low desire.
In men, PT-141 is used off-label to address low libido specifically. It is most often considered by men who get an adequate response from an ED medication but have noticed that interest itself has declined, and it can be used alongside those medications under physician supervision.
A Discreet, Physician-Guided Conversation
Low libido is frequently a symptom of something else — thyroid function, testosterone, sleep apnea, medication side effects, or stress. That is why PT-141 therapy at RevitalIV starts with a consultation and lab work rather than a prescription. Dr. Brown reviews your results with you and recommends a direction based on what is actually driving the change.
Consultations are private and unhurried. Call (561) 406-2202 or book online.